Ventero-Nova^® (Tablets) Instructions for Use

Marketing Authorization Holder

Baiyunshan Qixing Pharmaceutical Company (China)

ATC Code

A02BX (Other drugs for the treatment of gastric and duodenal ulcers and GERD)

Dosage Form

Ventero-Nova®

Coated tablets: 24 pcs.

Dosage Form, Packaging, and Composition

Coated tablets from light green to greenish-gray in color, round, biconvex. The cross-section shows two layers. The outer layer is the coating from light greenish to greenish-gray in color. The inner layer is from light brown with a greenish tint to dark brown with a greenish tint.

Excipients: sucrose 5.46 mg, talc 3.58 mg, hydroxy methylcellulose 3.38 mg, polyacrylate 3.2 mg, titanium dioxide 2 mg, polysorbate-80 2 mg, copper chlorophyll 2 mg.

12 pcs. – blisters (2) – aluminum foil bags (1) – cardboard packs.

Clinical-Pharmacological Group

Herbal preparation, used for gastrointestinal tract diseases

Pharmacotherapeutic Group

Peptic ulcer herbal treatment agent

Pharmacological Action

A combined preparation of natural origin, the pharmacological action of which is determined by the combined properties of its constituent components.

It has antisecretory and antacid activity, helps stimulate regenerative processes in the gastric and duodenal mucosa; exerts anti-inflammatory, antimicrobial, antispasmodic action; contributes to the improvement of the motor function of the stomach and duodenum.

Indications

• As part of the complex therapy of chronic gastritis with increased secretory activity;
• Chronic gastroduodenitis;
• Gastric and duodenal ulcer.

ICD codes

Dosage Regimen

Administer orally.

For adults only.

Take 3 tablets per dose.

Dose frequency is 2-3 times daily.

Take doses 1 hour before meals or 2 hours after meals.

The standard treatment course is 30 days.

Complete the full course as directed.

Do not exceed the recommended dosage.

Adverse Reactions

When using the drug for the indicated indications in recommended dosages, side effects have not been identified. Allergic reactions are possible.

Contraindications

• Hypersensitivity to the drug components;
• Atrophic gastritis;
• Pregnancy;
• Breastfeeding period;
• Age under 18 years.

The drug contains sucrose, therefore it should not be used in patients with rare hereditary conditions such as fructose intolerance, glucose/galactose malabsorption syndrome, or sucrase/isomaltase deficiency.

Use in Pregnancy and Lactation

It is prohibited to take the drug during pregnancy and lactation.

Pediatric Use

It is prohibited to take the drug for children under 18 years of age.

Special Precautions

The drug contains sucrose in an amount of about 1% of the tablet mass, which should be considered by persons suffering from diabetes mellitus. One single dose of the drug (3 tablets) contains 0.01638 g of sucrose, which corresponds to 0.00136 Bread Units (XE).

During treatment, one should refrain from consuming excessively acidic or spicy foods and beverages.

Drug Interactions

None identified.

Storage Conditions

The drug should be stored at a temperature from 15 to 25°C (77°F), in a dry place, protected from light. Keep out of reach of children.

Shelf Life

Shelf life – 3 years.

Do not use after the expiration date.

Dispensing Status

The drug is dispensed by prescription.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.